Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
NILEMDO Filmtabl 180 mg 98 Stk
Drug
Nilemdo, Filmtabletten
Primäre Hypercholesterinämie (heterozygot familiär und nicht-familiär)
07.12.0. – lipid lowering agents
HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
12/14/2020
12/13/2025
Dosage strength
Nilemdo 180 mg, Filmtabletten
Primäre Hypercholesterinämie (heterozygot familiär und nicht-familiär)
01
Z – approved
Package
7680675830022
No information made available
A/R – Authorised / referenced
98 mg
002
Z – approved
Declaration
Component
180 mg acidum bempedoicum
cellulosum microcristallinum
30 mg lactosum monohydricum
hydroxypropylcellulosum
silica colloidalis anhydrica
carboxymethylamylum natricum
0.97 mg natrium
magnesii stearas
poly(alcohol vinylicus)
macrogolum
talcum
E 171
30 mg lactosum monohydricum
hydroxypropylcellulosum
silica colloidalis anhydrica
carboxymethylamylum natricum
0.97 mg natrium
magnesii stearas
poly(alcohol vinylicus)
macrogolum
talcum
E 171
Spezialitätenliste***
SL
-
-
198.00
None
Yes
10%
No
Authorisation holder
7601001308855
Daiichi Sankyo (Schweiz) AG
Vulkanstrasse 106
8048 Zürich (ZH)
Vulkanstrasse 106
8048 Zürich (ZH)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.